Login Register Cart 0
Generic placeholder image

Drug Delivery Letters

Editor-in-Chief

ISSN (Print): 2210-3031
ISSN (Online): 2210-304X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Development of NLC- based Sunscreen Gel of Lutein and its in-vitro and ex-vivo Characterisation

Author(s): Bhawna Sharma*, Iti Chauhan and Alok Pratap Singh

Volume 13, Issue 1, 2023

Published on: 18 January, 2023

Page: [69 - 81] Pages: 13

DOI: 10.2174/2210303113666221227145210

Price: $65

Abstract

Background: In humans, Carotenoids are important in scavenging singlet oxygen and peroxyl radicals. Lutein has been demonstrated in multiple studies to help protect the skin from photodamage, as well as provide a variety of other health advantages. In the recent decade, the topical use of Lutein as a new ultraviolet (UV) protectant, anti-stress, and blue light filter capable of protecting skin from photodamage has piqued cosmetic and pharmacological attention. Because Lutein is insoluble, it was integrated into nanocarriers for topical administration.

Objective: The objective of this study was to formulate an NLC-based sunscreen gel of Lutein.

Methods: Nanostructured lipid carriers (NLC) were prepared by melt emulsion ultrafiltration technique and were evaluated for particle size, zeta potential, polydispersity index (PDI), drug loading (DL), encapsulation efficacy (EE), and in vitro drug release. The optimised formula was incorporated into a gel base and an in-vitro sun protection factor (SPF) was determined. Ex- vivo permeation study was performed on rat skin using a Franz diffusion cell. Cocoa butter and rose oil were chosen as solid and liquid lipids for NLC formulation.

Results: The particle size, PDI, zeta potential, entrapment efficiency, and in vitro drug release of optimised formulation (NLC5) were found to be 81.64 nm, 0.463, -14.1mV, 79.90 %, and 89.86% respectively. The SPF value of the Lutein-NLC-loaded gel was found to be 27.524. The drug flux Jss from NLC gel was measured in the range of 0.07955 g/cm2/h.

Conclusion: The investigation suggested lipid nanoparticles as a suitable carrier for Lutein to be delivered as sunscreen gel.

« Previous
Graphical Abstract

[1]
Shi, L.; Shan, J.; Ju, Y.; Aikens, P.; Prud’homme, R.K. Nanoparticles as delivery vehicles for sunscreen agents. Colloids Surf. A Physicochem. Eng. Asp., 2012, 396, 122-129.
[http://dx.doi.org/10.1016/j.colsurfa.2011.12.053]
[2]
Roberts, R.L.; Green, J.; Lewis, B. Lutein and zeaxanthin in eye and skin health. Clin. Dermatol., 2009, 27(2), 195-201.
[http://dx.doi.org/10.1016/j.clindermatol.2008.01.011] [PMID: 19168000]
[3]
Tsao, R.; Yang, R.; Young, J.C.; Zhu, H.; Manolis, T. Separation of geometric isomers of native lutein diesters in marigold (Tagetes erecta L.) by high-performance liquid chromatography-mass spectrometry. J. Chromatogr. A, 2004, 1045(1-2), 65-70.
[http://dx.doi.org/10.1016/j.chroma.2004.06.020] [PMID: 15378880]
[4]
Tan, Z.D. OU, Z.T. Extraction of Lutein ester from marigold petals and its clathration with β-cyclodextrin. Int. J. Eng. Res. Sci., 2016, 2(8)
[5]
Sies, H.; Stahl, W. Carotenoids and UV protection. Photochem. Photobiol. Sci., 2004, 3(8), 749-752.
[http://dx.doi.org/10.1039/b316082c] [PMID: 15295630]
[6]
Alves-Rodrigues, A.; Shao, A. The science behind lutein. Toxicol. Lett., 2004, 150(1), 57-83.
[http://dx.doi.org/10.1016/j.toxlet.2003.10.031] [PMID: 15068825]
[7]
Huang, J.; Bai, F.; Wu, Y.; Ye, Q.; Liang, D.; Shi, C.; Zhang, X. Development and evaluation of lutein‐loaded alginate microspheres with improved stability and antioxidant. J. Sci. Food Agric., 2019, 99(11), 5195-5201.
[http://dx.doi.org/10.1002/jsfa.9766] [PMID: 31032964]
[8]
Mitri, K.; Shegokar, R.; Gohla, S.; Anselmi, C.; Müller, R.H. Lipid nanocarriers for dermal delivery of lutein: Preparation, characterization, stability and performance. Int. J. Pharm., 2011, 414(1-2), 267-275.
[http://dx.doi.org/10.1016/j.ijpharm.2011.05.008] [PMID: 21596122]
[9]
Elsayed, A.; Belal, A. Formulation, characterization and in-vitro evaluation of solid lipid nanoparticles for the delivery of a new anticancer agent, 1H-pyrazolo[3,4-d] pyrimidine derivative. Trop. J. Pharm. Res., 2022, 20(5), 885-891.
[http://dx.doi.org/10.4314/tjpr.v20i5.1]
[10]
Whitner, T.C.; Bailey, H.S. Melting point determination of lard substitutes. J. Oil Fat Ind., 1922, 5(10), 30-32.
[http://dx.doi.org/10.1007/BF03040032]
[11]
Gaba, B.; Fazil, M.; Khan, S.; Ali, A.; Baboota, S.; Ali, J. Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride. Bull. Fac. Pharm. Cairo Univ., 2015, 53(2), 147-159.
[http://dx.doi.org/10.1016/j.bfopcu.2015.10.001]
[12]
Fernandes, A.V.; Pydi, C.R.; Verma, R.; Jose, J.; Kumar, L. Design, preparation and in vitro characterizations of fluconazole loaded nanostructured lipid carriers. Braz. J. Pharm. Sci., 2020, 56, e18069.
[http://dx.doi.org/10.1590/s2175-97902019000318069]
[13]
Sharma, J.B.; Bhatt, S.; Saini, V.; Kumar, M. Pharmacokinetics and pharmacodynamics of curcumin-loaded solid lipid nanoparticles in the management of streptozotocin-induced diabetes mellitus: Application of central composite design. Assay Drug Dev. Technol., 2021, 19(4), 262-279.
[http://dx.doi.org/10.1089/adt.2021.017] [PMID: 34000202]
[14]
Unnisa, A.; Chettupalli, A.K.; Al Hagbani, T.; Khalid, M.; Jandrajupalli, S.B.; Chandolu, S.; Hussain, T. Development of dapagliflozin solid lipid nanoparticles as a novel carrier for oral delivery: statistical design, optimization, in-vitro and in-vivo characterization, and evaluation. Pharmaceuticals, 2022, 15(5), 568.
[http://dx.doi.org/10.3390/ph15050568] [PMID: 35631394]
[15]
Deep, A.; Kumar, M.; Pahwa, R.; Gupta, S.; Bhatt, S.; Kumari, B.; Upadhyay, P.K.; Pandurangan, A. Formulation and in vivo pharmacodynamics studies of nanostructured lipid carriers for topical delivery of bifonazole. ACTA Pharmaceutica Sciencia, 2021, 59(1), 559-580.
[http://dx.doi.org/10.23893/1307-2080.APS.05902]
[16]
Dar, A.; Anuradha, N. Use of orthogonal arrays and design of experiment via Taguchi L9 method in probability of default. Accounting, 2018, 4(3), 113-122.
[17]
Singh, A.P.; Sharma, S.K.; Gaur, P.K.; Gupta, D.K. Fabrication of mupirocin-loaded nanostructured lipid carrier and its in vitro characterization. Assay Drug Dev. Technol., 2021, 19(4), 216-225.
[http://dx.doi.org/10.1089/adt.2020.1070] [PMID: 33781090]
[18]
Uprit, S.; Kumar Sahu, R.; Roy, A.; Pare, A. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm. J., 2013, 21(4), 379-385.
[http://dx.doi.org/10.1016/j.jsps.2012.11.005] [PMID: 24227958]
[19]
Patel, D.; Dasgupta, S.; Dey, S.; Ramani, Y.R.; Ray, S.; Mazumder, B. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. Sci. Pharm., 2012, 80(3), 749-764.
[http://dx.doi.org/10.3797/scipharm.1202-12] [PMID: 23008819]
[20]
Sütő, B.; Berkó, S.; Kozma, G.; Kukovecz, Á.; Budai-Szűcs, M.; Erős, G.; Kemény, L.; Sztojkov-Ivanov, A.; Gáspár, R.; Csányi, E. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin. Int. J. Nanomedicine, 2016, 11, 1201-1212.
[PMID: 27099487]
[21]
Agrawal, Y.; Petkar, K.C.; Sawant, K.K. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int. J. Pharm., 2010, 401(1-2), 93-102.
[http://dx.doi.org/10.1016/j.ijpharm.2010.09.007] [PMID: 20858539]
[22]
Shinde, S.; Ghorpade, K.; Gattani, S.G. Design and development of boswellic acid loaded nanostructured lipid carrier based anti psoriatic nano gel for dermal delivery. World J. Pharm. Res., 2019, 8(7), 1045-1061.
[23]
Joshi, M.; Patravale, V. Nanostructured Lipid Carrier (NLC) based gel of celecoxib. Int. J. Pharm., 2008, 346(1-2), 124-132.
[http://dx.doi.org/10.1016/j.ijpharm.2007.05.060] [PMID: 17651933]
[24]
Joshi, M.; Patravale, V. Formulation and evaluation of Nanostructured Lipid Carrier (NLC)-based gel of Valdecoxib. Drug Dev. Ind. Pharm., 2006, 32(8), 911-918.
[http://dx.doi.org/10.1080/03639040600814676] [PMID: 16954103]
[25]
Ijaz, M.; Akhtar, N. Fatty acids based α-Tocopherol loaded nanostructured lipid carrier gel: In vitro and in vivo evaluation for moisturizing and anti-aging effects. J. Cosmet. Dermatol., 2020, 19(11), 3067-3076.
[http://dx.doi.org/10.1111/jocd.13346] [PMID: 32129554]
[26]
Netto MPharm, G.; Jose, J.; Jose, J. Development, characterization, and evaluation of sunscreen cream containing solid lipid nanoparticles of silymarin. J. Cosmet. Dermatol., 2018, 17(6), 1073-1083.
[http://dx.doi.org/10.1111/jocd.12470] [PMID: 29226503]
[27]
Merlin, F.P.; Ratnasooriya, W.D.; Pathirana, R.N. In vitro investigation of sunscreen activity and evaluation of phytochemical profile of Methanolic leaf extract of Rauvolfia tetraphylla. J. Pharmacogn. Phytochem., 2020, 9(2), 2063-2067.
[28]
Das, B.; Sen, S.O.; Maji, R.; Nayak, A.K.; Sen, K.K. Transferosomal gel for transdermal delivery of risperidone: Formulation optimization and ex vivo permeation. J. Drug Deliv. Sci. Technol., 2017, 38, 59-71.
[http://dx.doi.org/10.1016/j.jddst.2017.01.006]
[29]
Jiao, Y.; Zheng, X.; Chang, Y.; Li, D.; Sun, X.; Liu, X. Zein-derived peptides as nanocarriers to increase the water solubility and stability of lutein. Food Funct., 2018, 9(1), 117-123.
[http://dx.doi.org/10.1039/C7FO01652B] [PMID: 29336438]
[30]
Gilani, S.J.; Jumah, M.N.; Zafar, A.; Imam, S.S.; Yasir, M.; Khalid, M.; Alshehri, S.; Ghuneim, M.M.; Albohairy, F.M. Formulation and evaluation of nano lipid carrier-based ocular gel system: optimization to antibacterial activity. Gels, 2022, 8(5), 255.
[http://dx.doi.org/10.3390/gels8050255] [PMID: 35621552]
[31]
Malik, D.S.; Kaur, G. Nanostructured gel for topical delivery of azelaic acid: Designing, characterization, and in-vitro evaluation. J. Drug Deliv. Sci. Technol., 2018, 47, 123-136.
[http://dx.doi.org/10.1016/j.jddst.2018.07.008]
[32]
Niculae, G.; Badea, N.; Meghea, A.; Oprea, O.; Lacatusu, I. Coencapsulation of butyl-methoxydibenzoylmethane and octocrylene into lipid nanocarriers: UV performance, photostability and in vitro release. Photochem. Photobiol., 2013, 89(5), 1085-1094.
[http://dx.doi.org/10.1111/php.12117] [PMID: 23789784]
[33]
Imran, M.; Iqubal, M.K.; Imtiyaz, K.; Saleem, S.; Mittal, S.; Rizvi, M.M.A.; Ali, J.; Baboota, S. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Int. J. Pharm., 2020, 587, 119705.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119705] [PMID: 32738456]
[34]
Lacatusu, I.; Badea, N.; Murariu, A.; Meghea, A. The encapsulation effect of UV molecular absorbers into biocompatible lipid nanoparticles. Nanoscale Res. Lett., 2011, 6(1), 73.
[http://dx.doi.org/10.1186/1556-276X-6-73] [PMID: 21711592]
[35]
Bhaskar, K.; Krishna Mohan, C.; Lingam, M.; Prabhakar Reddy, V.; Venkateswarlu, V.; Madhusudan Rao, Y. Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: in vitro and ex vivo characterization. Drug Dev. Ind. Pharm., 2008, 34(7), 719-725.
[http://dx.doi.org/10.1080/03639040701842485] [PMID: 18612912]
[36]
Joseph, J. B N, V.H.; D, R.D. Experimental optimization of Lornoxicam liposomes for sustained topical delivery. Eur. J. Pharm. Sci., 2018, 112, 38-51.
[http://dx.doi.org/10.1016/j.ejps.2017.10.032] [PMID: 29111151]
[37]
Chen, P.C.; Huang, J.W.; Pang, J. An investigation of optimum NLC-sunscreen formulation using taguchi analysis. J. Nanomater., 2013, 2013, 1-10.
[http://dx.doi.org/10.1155/2013/463732]
[38]
Costa, S.C.C.; Detoni, C.B.; Branco, C.R.C.; Botura, M.B.; Branco, A. In vitro photoprotective effects of Marcetia taxifolia ethanolic extract and its potential for sunscreen formulations. Rev. Bras. Farmacogn., 2015, 25(4), 413-418.
[http://dx.doi.org/10.1016/j.bjp.2015.07.013]
[39]
Silva-Abreu, M.; Espinoza, L.; Halbaut, L.; Espina, M.; García, M.; Calpena, A. Comparative study of ex vivo transmucosal permeation of pioglitazone nanoparticles for the treatment of Alzheimer’s disease. Polymers (Basel), 2018, 10(3), 316.
[http://dx.doi.org/10.3390/polym10030316] [PMID: 30966351]
[40]
National Center for Biotechnology Information (2022).. PubChem Compound Summary for CID 5281243, Lutein. 2022. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Lutein
[41]
Which sunscreen should I use? Available from: https://www.medicalnewstoday.com/articles/306838#what-is-sun-protection-factor

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy